Trial Profile
Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Tritanrix-HepB Low Thio/Hib2.5 Godollo Compared to GSK Biologicals' Tritanrix-HepB/Hiberix Godollo When Administered as a 3-dose Primary Vaccination Course to Healthy Infants
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Hib-DTP hepatitis B vaccine (Tritanrix-HepB/Hiberix) (Primary) ; DTP-hepatitis B vaccine; Hib vaccine
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 13 Feb 2010 New trial record